Novo Nordisk shares plunge 22% after CagriSema obesity drug trial results
Shares of Danish pharmaceutical giant Novo Nordisk plummeted more than 22% on Friday after reporting results in a late-stage trial that missed expectations.
In computational chemistry, molecules are often represented as molecular graphs, which must be converted into multidimensional vectors for processing, particularly…